Airduo Respiclick

Active Ingredient(s): Fluticasone Propionate + Salmeterol Xinafoate
FDA Approved: * January 27, 2017
Pharm Company: * TEVA PHARM
Category: Asthma

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Airduo Respiclick Overview

The combination preparation fluticasone/salmeterol is a formulation containing fluticasone propionate and salmeterol xinafoate, used in the management of asthma and chronic obstructive pulmonary disease (COPD). Patent protection in the US expired in 2010, and European patent protection expired in 2013. However, the availability of a generic form of Advair in the United States may be significantly delayed because the Food and Drug Administration has not determined a standard for the bioequival...

Read more Airduo Respiclick Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Fluticasone/salmeterol

Recent Airduo Respiclick Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Fluticasone Propionate + Salmeterol Xinafoate
  • Aerosol, Metered: 0.045mg/inh + 0.021mg/inh, 0.115mg/inh + 0.021mg/inh, 0.23mg/inh + 0.021mg/inh, 115mcg + 21mcg, 230mcg + 21mcg, 45mcg + 21mcg
  • Inhalant: 100mcg/actuation + 50mcg/actuation, 250mcg/actuation + 50mcg/actuation, 500mcg/actuation + 50mcg/actuation
  • Powder: 0.055mg/inh + 0.014mg/inh, 0.113mg/inh + 0.014mg/inh, 0.232mg/inh + 0.014mg/inh
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Drugs with one or more similar ingredients: (6 results)